Department of Neurology Archives
Using a mapping technique to reassess prior Alzheimer’s studies finds ‘powerful,’ improved reproducibility
Dec. 19, 2018—A neural mapping approach that pegs results from more than two dozen previous Alzheimer’s studies found that reproducibility improves when trying to isolate symptoms to a brain network rather than a single area of the brain.
Oct. 26, 2018—A new link between a support protein within the brain's white matter and known Alzheimer's biomarkers discovered by Angela Jefferson and colleagues bring researchers a step toward earlier and more precise detection of neuropathology underlying cognitive impairment that may lead to new targeted therapies
Oct. 4, 2018—Using lesion network mapping, a recently developed technique for analyzing how the brain works, Ryan Darby studied free will perception related to movement decisions.
Aug. 30, 2018—A symptom related to hypertension may play a role in cognitive decline, according to new research by Angela Jefferson.
Jun. 21, 2018—A sleep apnea diagnosis can often be the start to a healthier and better life.
May. 30, 2018—The Vanderbilt Multiple Sclerosis Center has opened a relapse clinic that offers expedited access for patients experiencing disease flare-ups.
May. 7, 2018—The APOE gene, the strongest genetic risk factor for Alzheimer’s disease, may play a more prominent role in disease development among women than men, according to new research from the Vanderbilt Memory and Alzheimer’s Center.
Feb. 8, 2018—Thomas “Tom” Davis, MD, enjoys archery when he’s not treating people with movement disorders.
Dec. 18, 2017—When brain lesions occur within the brain network responsible for morality and value-based decision-making, they can predispose a person toward criminal behavior, according to new research by Ryan Darby, MD, assistant professor of Neurology at Vanderbilt University Medical Center (VUMC).
Sep. 20, 2017—An interdisciplinary team of Vanderbilt University researchers has received a two-year, $2-million federal grant to develop an “organ-on-chip” model for two genetic forms of epilepsy.